These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 10069875)

  • 101. Low-dose methotrexate treatment in severe glucocorticoid-dependent asthma: effect on mucosal inflammation and in vitro sensitivity to glucocorticoids of mitogen-induced T-cell proliferation.
    Vrugt B; Wilson S; Bron A; Shute J; Holgate ST; Djukanovic R; Aalbers R
    Eur Respir J; 2000 Mar; 15(3):478-85. PubMed ID: 10759440
    [TBL] [Abstract][Full Text] [Related]  

  • 102. Nocturnal asthma is associated with reduced glucocorticoid receptor binding affinity and decreased steroid responsiveness at night.
    Kraft M; Vianna E; Martin RJ; Leung DY
    J Allergy Clin Immunol; 1999 Jan; 103(1 Pt 1):66-71. PubMed ID: 9893187
    [TBL] [Abstract][Full Text] [Related]  

  • 103. Suppression of the immune system by oral glucocorticoid therapy in bronchial asthma.
    Oehling AG; Akdis CA; Schapowal A; Blaser K; Schmitz M; Simon HU
    Allergy; 1997 Feb; 52(2):144-54. PubMed ID: 9105518
    [TBL] [Abstract][Full Text] [Related]  

  • 104. Phenotype-Specific Therapeutic Effect of
    Pang Z; Ran N; Yuan Y; Wang C; Wang G; Lin H; Hsu AC; Liu J; Wang F
    Int J Mol Sci; 2019 Aug; 20(17):. PubMed ID: 31466312
    [TBL] [Abstract][Full Text] [Related]  

  • 105. Potential therapeutic targets for steroid-resistant asthma.
    Wang W; Li JJ; Foster PS; Hansbro PM; Yang M
    Curr Drug Targets; 2010 Aug; 11(8):957-70. PubMed ID: 20412045
    [TBL] [Abstract][Full Text] [Related]  

  • 106. Steroid resistance in asthma: mechanisms and treatment options.
    Adcock IM; Ford PA; Bhavsar P; Ahmad T; Chung KF
    Curr Allergy Asthma Rep; 2008 Apr; 8(2):171-8. PubMed ID: 18417060
    [TBL] [Abstract][Full Text] [Related]  

  • 107. Perimenstrual asthma: Report of a case with therapeutic intervention of oral prednisone.
    Lei Z; Yanhan D; Yi W; Shengdao X; Weining X
    J Asthma; 2018 Dec; 55(12):1328-1330. PubMed ID: 29584459
    [TBL] [Abstract][Full Text] [Related]  

  • 108. Steroid resistance in asthma: our current understanding.
    Kamada AK; Leung DY; Szefler SJ
    Pediatr Pulmonol; 1992 Nov; 14(3):180-6. PubMed ID: 1480444
    [TBL] [Abstract][Full Text] [Related]  

  • 109. Molecular basis for corticosteroid action in asthma.
    Barnes PJ
    Chem Immunol; 2000; 78():72-80. PubMed ID: 12847720
    [No Abstract]   [Full Text] [Related]  

  • 110. Reversing the defective induction of IL-10-secreting regulatory T cells in glucocorticoid-resistant asthma patients.
    Xystrakis E; Kusumakar S; Boswell S; Peek E; Urry Z; Richards DF; Adikibi T; Pridgeon C; Dallman M; Loke TK; Robinson DS; Barrat FJ; O'Garra A; Lavender P; Lee TH; Corrigan C; Hawrylowicz CM
    J Clin Invest; 2006 Jan; 116(1):146-55. PubMed ID: 16341266
    [TBL] [Abstract][Full Text] [Related]  

  • 111. The role of immunoglobulin therapy in allergic diseases.
    Rabinovitch N; Gelfand EW; Leung DY
    Allergy; 1999 Jul; 54(7):662-8. PubMed ID: 10442521
    [TBL] [Abstract][Full Text] [Related]  

  • 112. Strategies for improving the efficacy and therapeutic ratio of glucocorticoids.
    Adcock IM; Caramori G; Kirkham PA
    Curr Opin Pharmacol; 2012 Jun; 12(3):246-51. PubMed ID: 22445282
    [TBL] [Abstract][Full Text] [Related]  

  • 113. Glucocorticoid-resistant asthma: pathogenesis and clinical implications for management.
    Szefler SJ; Leung DY
    Eur Respir J; 1997 Jul; 10(7):1640-7. PubMed ID: 9230260
    [TBL] [Abstract][Full Text] [Related]  

  • 114. Lymphocyte glucocorticoid receptors in asthmatic and control subjects.
    Tsai BS; Watt G; Koesnadi K; Townley RG
    Clin Allergy; 1984 Jul; 14(4):363-71. PubMed ID: 6467559
    [TBL] [Abstract][Full Text] [Related]  

  • 115. Development of highly potent glucocorticoids for steroid-resistant severe asthma.
    He Y; Shi J; Nguyen QT; You E; Liu H; Ren X; Wu Z; Li J; Qiu W; Khoo SK; Yang T; Yi W; Sun F; Xi Z; Huang X; Melcher K; Min B; Xu HE
    Proc Natl Acad Sci U S A; 2019 Apr; 116(14):6932-6937. PubMed ID: 30894497
    [TBL] [Abstract][Full Text] [Related]  

  • 116. Mononuclear leukocyte glucocorticoid receptor binding characteristics and down-regulation in major depression.
    Wassef A; Smith EM; Rose RM; Gardner R; Nguyen H; Meyer WJ
    Psychoneuroendocrinology; 1990; 15(1):59-68. PubMed ID: 2367616
    [TBL] [Abstract][Full Text] [Related]  

  • 117. High-dose systemic glucocorticoid therapy in the treatment of severe asthma: a case of resistance and patterns of response.
    Kamada AK; Leung DY; Gleason MC; Hill MR; Szefler SJ
    J Allergy Clin Immunol; 1992 Oct; 90(4 Pt 1):685-7. PubMed ID: 1401649
    [No Abstract]   [Full Text] [Related]  

  • 118. Molecular mechanisms of glucocorticoid resistance.
    Huang H; Wang W
    Eur J Clin Invest; 2023 Feb; 53(2):e13901. PubMed ID: 36346177
    [TBL] [Abstract][Full Text] [Related]  

  • 119. Comparative efficacy of glucocorticoid receptor agonists on Th2 cell function and attenuation by progesterone.
    Luchak A; Solomon LA; Kanagalingam T; Vijeyakumaran M; Rowe BH; Cameron L
    BMC Immunol; 2020 Oct; 21(1):54. PubMed ID: 33076829
    [TBL] [Abstract][Full Text] [Related]  

  • 120. Clinical immunopharmacology of autoimmune neuropathies and myopathies.
    Gordon AJ; Meriggioli MN
    Clin Neuropharmacol; 2002; 25(3):174-81. PubMed ID: 12023571
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.